
A Northeastern University researcher has won a $1.4 million grant from the National Institutes of Health to develop nanocarrier drug delivery technology.
Vladimir Torchilin, a professor pharmaceutical sciences and the director of Northeastern’s Center for Pharmaceutical Biotechnology and Biomedicine, will use the funding to combine pharmaceutical nanotechnology with a new drug coating process. The combination of techniques is intended to carry insoluble drugs to their targets inside the body. The technique could make drugs passed over for their insolubility viable drug candidates again.
Torchilin will collaborate with researchers from Louisiana Tech University on the four-year grant.
In 2008, Torchilin won $1.5 million from the NIH for research on nanoscale pharmaceuticals.




Print
Email
Print Edition Stories




Comments
Please Login/Register to post comments.
No comments have been added or approved.